Medizinische Universit├Ąt Graz - Research portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid

Wackernagel, W; Tarmann, L; Mayer, C; Langmann, G; Wedrich, A; .
Genetic analysis of uveal melanoma by array comparative genomic hybridization before and after radiotherapy.
SPEKTRUM AUGENHEILKD. 2013; 27(6): 286-291.
Web of Science FullText FullText_MUG

 

Authors Med Uni Graz:
Langmann Gerald
Mayer-Xanthaki Christoph
Vajda Lisa
Wackernagel Werner
Wedrich Andreas
Altmetrics:

Dimensions Citations:
Plum Analytics:

Abstract:
Background Genetic analysis of choroidal melanoma is frequently used to estimate the risk of metastatic spread of the tumor. Obtaining a biopsy for genetic analysis, however, can be difficult and sometimes unsuccessful. We evaluated the feasibility and accuracy of genetic testing using array comparative genomic hybridization (CGH) after radiotherapy, from tumor samples obtained by endoresection or after secondary enucleation. Material and methods Fifteen choroidal melanoma samples obtained after radiotherapy (Ruthenium-106 plaque brachytherapy or Gamma-Knife radiosurgery) were analyzed by array CGH to detect chromosomal aberrations (monosomy 3 and trisomy 8q), and the results were compared with pre-irradiation findings in five cases. Results Array CGH was successfully performed in all 15 cases. Time from radiotherapy to obtaining the sample for cytogenetic testing was between 14 and 879 days. Results of post-radiotherapy genetic analysis did not differ from pre-radiotherapy findings. Conclusion Post-radiation CGH appears to be a promising option for prognostic testing if a first biopsy before radiotherapy failed or was not performed. It could be useful to avoid an additional surgical procedure before radiotherapy if vitrectomy or endoresection is planned after radiotherapy.

Find related publications in this database (Keywords)
Choroidal melanoma
Genetic testing
CGH
Radiotherapy
Endoresection
© Meduni GrazImprint